Susquehanna International Group
PASG icon

Susquehanna International Group’s Passage Bio PASG Stock Holding History

Susquehanna International Group’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-535
Closed -$68K – 13719
2021
Q4 		$68K Buy
+535
New +$87.4K ﹤0.01% 12397

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's PASG Position: Q1 2024 in Review

Susquehanna International Group sold out of Passage Bio (PASG) in Q1 2024, closing a stake of 927 shares — an estimated $18.7K sold.

Susquehanna International Group first reported a position in PASG in Q1 2021 and held it in 4 quarters. The position peaked at $414K in Q2 2021. 48 funds tracked by Wall St. Rank hold PASG as of Q1 2024.

  • Susquehanna International Group reported no remaining Passage Bio position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 927 Passage Bio shares in Q1 2024, an estimated $18.7K.
  • Susquehanna International Group first reported a position in Passage Bio in Q1 2021 and held it in 4 quarters.
  • Susquehanna International Group's Passage Bio position peaked at $414K in Q2 2021.
  • 48 funds tracked by Wall St. Rank held Passage Bio as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.